Medicare Enrolled
Dr. Anthony Santoro, M.D.
MOHS-Micrographic Surgery Physician · Doylestown, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Santoro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Santoro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Santoro
Dr. Anthony Santoro is a mohs-micrographic surgery physician in Doylestown, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Santoro performed 5,903 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Santoro received a total of $7,565 from 34 pharmaceutical and/or device companies across 363 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Santoro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 19% volume in PA
$7,565 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,903
Medicare services
Top 19% in PA for mohs-micrographic surgery physician
Not available
Unique patients (not deduplicated)
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,683 | $3 | $55 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
794 | $53 | $138 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
786 | $41 | $201 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
456 | $40 | $269 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
381 | $77 | $202 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
216 | $72 | $281 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
158 | $25 | $147 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
149 | $38 | $93 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
99 | $65 | $204 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
63 | $97 | $553 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $108 | $300 |
| Skin growth biopsy, first lesion A minor surgical procedure to remove a small sample of tissue from a skin growth for laboratory examination. |
16 | $38 | $500 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
15 | $48 | $160 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
14 | $78 | $820 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
14 | $205 | $950 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
13 | $66 | $300 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
12 | $111 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,565
Total received (2018-2024)
Avg $1,081/year across 7 years
Top 15% in PA for mohs-micrographic surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
363
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,286
2023
$1,437
2022
$1,451
2021
$909
2020
$482
2019
$1,033
2018
$968
Payments by company (2024)
Janssen Biotech, Inc.
$432
Amgen Inc.
$237
ABBVIE INC.
$140
Arcutis Biotherapeutics, Inc.
$101
Helsinn Therapeutics (U.S.), Inc.
$76
Regeneron Healthcare Solutions, Inc.
$67
Lilly USA, LLC
$64
SUN PHARMACEUTICAL INDUSTRIES INC.
$44
Integra LifeSciences Corporation
$44
E.R. Squibb & Sons, L.L.C.
$41
Blueprint Medicines Corporation
$21
UCB, Inc.
$17
Top 3 companies account for 62.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,038
Regeneron Healthcare Solutions, Inc.
$731
Janssen Scientific Affairs, LLC
$701
Amgen Inc.
$514
Helsinn Therapeutics (U.S.), Inc.
$427
ABBVIE INC.
$309
AbbVie Inc.
$283
Galderma Laboratories, L.P.
$244
E.R. Squibb & Sons, L.L.C.
$233
Almirall LLC
$225
LEO Pharma Inc.
$173
UCB, Inc.
$148
Arcutis Biotherapeutics, Inc.
$143
Incyte Corporation
$143
SUN PHARMACEUTICAL INDUSTRIES INC.
$132
Novartis Pharmaceuticals Corporation
$127
EPI Health, LLC
$117
Lilly USA, LLC
$116
AbbVie, Inc.
$113
Sun Pharmaceutical Industries Inc.
$113
Genentech USA, Inc.
$95
Mayne Pharma Inc.
$60
Mission Pharmacal Company
$49
Promius Pharma LLC
$47
Integra LifeSciences Corporation
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
GENZYME CORPORATION
$37
Merck Sharp & Dohme LLC
$37
Kerecis Limited
$33
DUSA Pharmaceuticals, Inc.
$31
Blueprint Medicines Corporation
$21
Sandoz Inc.
$14
Biofrontera Inc.
$14
PruGen, Inc. Pharmaceuticals
$13
Top 3 companies account for 45.9% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · APEXICON E · AYVAKIT · Aczone · Ameluz · BLU-U · Bimzelx · CLODERM · COSENTYX · Cimzia · Cloderm Cream · Cordran Tape · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · Erivedge · HUMIRA · Humira · ILUMYA · Ilumya · Integra · KEYTRUDA · Kerecis Omega3 SurgiClose · LEVULAN KERASTICK · LIBTAYO · OLUMIANT · OPZELURA · ORACEA · Odomzo · Otezla · PICATO · REMICADE · RINVOQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tremfya · Trianex · VALCHLOR · Veltin · WYNZORA · Winlevi · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Mohs-micrographic surgery physicians in nearby ZIP areas
17
County median income
$111,951
Nearest hospital to ZIP centroid (approximate)
DOYLESTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Santoro is a clinical cardiology specialist, with above-average Medicare volume (top 19% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Santoro experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Santoro performed 2,683 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Santoro receive payments from pharmaceutical companies?
Yes. Dr. Santoro received a total of $7,565 from 34 companies across 363 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Santoro's costs compare to other mohs-micrographic surgery physicians in Doylestown?
Dr. Santoro's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Santoro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Mohs-Micrographic Surgery Physicians in Doylestown
Browse mohs-micrographic surgery physicians in Doylestown ranked by procedure volume and transparency data.
Highest volume
Top Mohs-Micrographic Surgery Physicians in PA
Mohs-micrographic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Mohs-Micrographic Surgery Physicians in PA
Which PA mohs-micrographic surgery physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology